CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Deckers Outdoor
DECK
$17.7B
| $345K | 0.12% | 768 -1,561 | -67% | -$702K |
|
|
HZNP
102
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $338K | 0.11% | 3,094 +792 | +34% | +$86.4K |
|
103
Constellation Brands
STZ
$28.5B
| $324K | 0.11% | +1,436 | New | +$324K |
|
104
Dollar Tree
DLTR
$22.8B
| $285K | 0.1% | 1,983 -3,202 | -62% | -$460K |
|
|
FTCH
105
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $284K | 0.1% | +57,800 | New | +$284K |
|
106
Ralph Lauren
RL
$18B
| $284K | 0.1% | 2,416 +640 | +36% | +$75.1K |
|
107
Autoliv
ALV
$9.53B
| $280K | 0.09% | 3,000 | – | – |
|
108
BioNTech
BNTX
$24B
| $275K | 0.09% | 2,205 -16,860 | -88% | -$2.1M |
|
109
Hilton Worldwide
HLT
$64.9B
| $266K | 0.09% | 1,887 -1,100 | -37% | -$155K |
|
110
Allegro MicroSystems
ALGM
$5.71B
| $240K | 0.08% | +5,000 | New | +$240K |
|
111
Huazhu Hotels Group
HTHT
$11.3B
| $237K | 0.08% | 4,835 -15,465 | -76% | -$757K |
|
112
Sanofi
SNY
$121B
| $219K | 0.07% | 4,026 +1,091 | +37% | +$59.4K |
|
113
Incyte
INCY
$16.5B
| $218K | 0.07% | 3,021 +761 | +34% | +$55K |
|
114
Royalty Pharma
RPRX
$15.6B
| $216K | 0.07% | 6,005 +1,524 | +34% | +$54.9K |
|
|
DDL
115
Dingdong
DDL
$447M
| $207K | 0.07% | 53,514 -157,600 | -75% | -$608K |
|
116
Ross Stores
ROST
$48.1B
| $199K | 0.07% | 1,879 +104 | +6% | +$11K |
|
117
Pacific Biosciences
PACB
$393M
| $199K | 0.07% | 17,151 +1,051 | +7% | +$12.2K |
|
118
Zoom
ZM
$24.4B
| $186K | 0.06% | 2,514 +74 | +3% | +$5.46K |
|
119
Sarepta Therapeutics
SRPT
$1.78B
| $164K | 0.06% | 1,192 +300 | +34% | +$41.3K |
|
120
Zoetis
ZTS
$69.3B
| $164K | 0.06% | 986 | – | – |
|
121
Apellis Pharmaceuticals
APLS
$3.48B
| $156K | 0.05% | 2,366 +1,243 | +111% | +$82K |
|
122
Viatris
VTRS
$12.3B
| $156K | 0.05% | 16,216 +3,896 | +32% | +$37.5K |
|
123
argenx
ARGX
$43.6B
| $149K | 0.05% | 401 +85 | +27% | +$31.7K |
|
124
United Therapeutics
UTHR
$13.8B
| $141K | 0.05% | 628 +165 | +36% | +$37K |
|
125
Neurocrine Biosciences
NBIX
$13.8B
| $132K | 0.04% | 1,309 +332 | +34% | +$33.6K |
|